Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Brain Metastases|HER2 Positive
Interventions: DRUG: lapatinib and temozolomide
Sponsor: Jules Bordet Institute
Collaborators: GlaxoSmithKline|Schering-Plough